Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an Academic Gastrointestinal Cancer Consortium Study.

Saved in:
Bibliographic Details
Title: Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an Academic Gastrointestinal Cancer Consortium Study.
Authors: Cohen DJ; Division of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, United States., Goldberg JD; Division of Biostatistics, Department of Population Health, NYU Grossman School of Medicine, New York, NY, 10016, United States., Leichman L; Division of Hematology and Oncology, Perlmutter Cancer Institute, NYU Langone Health, New York, NY, 10016, United States., Hochman T; Division of Biostatistics, Department of Population Health, NYU Grossman School of Medicine, New York, NY, 10016, United States., Newman E; Division of Surgical Oncology, Northwell Health Lenox Hill Hospital, New York, NY, 10021, United States., Du K; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, 06519, United States., Megibow A; Division of Radiology, NYU Grossman School of Medicine, New York, NY, 10016, United States., Oberstein P; Division of Hematology and Oncology, Perlmutter Cancer Institute, NYU Langone Health, New York, NY, 10016, United States., Al-Rajabi R; Division of Medical Oncology, University of Kansas Medical Center, Kansas City, KS, 66160, United States., Scott AJ; Division of Hematology and Oncology, University of Arizona Cancer Center, Tucson, AZ, 85719, United States., Bekaii-Saab T; Division of Hematology and Oncology, Mayo Clinic Cancer Center, Phoenix, AZ, 85054, United States., Messersmith WA; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, 80262, United States., Weekes C; Division of Hematology and Oncology, Massachusetts General Cancer Center, Boston, MA, 02114, United States.
Source: The oncologist [Oncologist] 2025 Oct 01; Vol. 30 (10).
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1549-490X
DOI:10.1093/oncolo/oyaf271